M
$ Value
—
Shares
57,500
Price
—
Filed
May 12
Insider
Name
Nikzad Michael
Title
—
CIK
0001783048
Roles
Director
Transaction Details
Transaction Date
2025-05-08
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
157,500
Footnotes
On May 08, 2025, the 57,500 restricted stock units previously granted to Mr. Michael Nikzad under the Company's 2020 Omnibus Incentive Plan vested and converted into shares of the Company's common stock on a one-for-one basis.
Filing Info
Nikzad Michael's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-04 | CURI | M | — |
| 2026-02-04 | CURI | M | $0 |
| 2026-02-04 | CURI | A | $0 |
| 2025-05-08 | CURI | M | — |
| 2025-05-08 | CURI | M | — |
Other Insiders at CURI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HUBERMAN JONATHAN | — | — | 2026-02-04 |
| HENDRICKS JOHN S | — | — | 2026-02-04 |
| Blank Matthew | — | — | 2026-02-04 |
| Nikzad Michael | — | — | 2026-02-04 |
|
Stinchcomb Clinton Larry
President and CEO
|
— | — | 2026-03-11 |
| Hendricks Elizabeth Ann | — | — | 2026-02-04 |
| Keeley Patrick J. | — | — | 2026-02-04 |
| Hendricks Andrew | — | — | 2026-02-04 |
|
Hayden Phillip Brady
Chief Financial Officer
|
— | — | 2026-02-10 |
|
Reed Rebecca R
Gen Counsel
|
— | — | 2026-02-10 |
|
Vilade John Thomas Jr
Chief Commercial Officer
|
— | — | 2026-02-10 |